Novo buys rights to Chinese weight-loss pill in $2.6bn deal
The Danish firm acquires the drug from Hengrui Pharma, which could potentially be taken just once a week.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Novo
- Hengrui Pharma